Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases
- PMID: 11018123
- DOI: 10.1146/annurev.micro.54.1.19
Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases
Abstract
Adaptation of persistent infection within the cells of the immune system is a unique characteristic of gamma herpes viruses. A classic example of this is Epstein-Barr virus (EBV), which may have co-evolved with Homo sapiens over millions of years, thus achieving a balance between viral persistence and immune control. In this review, we present an overview of virus and the host immune system interactions that regulate the life-long host-virus relationship in healthy virus carriers and EBV-associated diseases. Extensive analysis of cytotoxic T lymphocyte-mediated immune responses in healthy virus carriers has revealed unique mechanisms used by EBV to maintain a benign persistent state in vivo. On the other hand, this relationship in EBV-associated diseases favors the escape of the virus from the hostile effects of the immune response. This escape is achieved by either down-regulating the expression of highly immunogenic antigens of the virus or by direct modulation of the host cytotoxic T lymphocyte response by virus-encoded proteins.
Similar articles
-
Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.Chin Med J (Engl). 2009 May 20;122(10):1173-8. Chin Med J (Engl). 2009. PMID: 19493466
-
EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.J Immunol. 1993 Jun 1;150(11):5154-62. J Immunol. 1993. PMID: 7684421
-
Immune surveillance against Epstein-Barr virus.Semin Immunol. 1992 Apr;4(2):97-104. Semin Immunol. 1992. PMID: 1377517 Review.
-
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.Semin Cancer Biol. 2008 Dec;18(6):409-15. doi: 10.1016/j.semcancer.2008.09.001. Epub 2008 Sep 30. Semin Cancer Biol. 2008. PMID: 18938248 Review.
-
The human T cell immune response to Epstein-Barr virus.Int J Dev Biol. 2005;49(2-3):285-92. doi: 10.1387/ijdb.041947el. Int J Dev Biol. 2005. PMID: 15906243
Cited by
-
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.Oncotarget. 2015 Jul 30;6(21):18653-63. doi: 10.18632/oncotarget.4418. Oncotarget. 2015. PMID: 26087198 Free PMC article.
-
Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.J Virol. 2005 May;79(9):5477-88. doi: 10.1128/JVI.79.9.5477-5488.2005. J Virol. 2005. PMID: 15827162 Free PMC article.
-
Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.J Clin Immunol. 2004 Mar;24(2):125-34. doi: 10.1023/B:JOCI.0000019777.75784.6f. J Clin Immunol. 2004. PMID: 15024179
-
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.Mult Scler. 2014 Dec;20(14):1825-32. doi: 10.1177/1352458514536252. Epub 2014 May 19. Mult Scler. 2014. PMID: 24842963 Free PMC article.
-
Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression.J Virol. 2009 Jun;83(12):6192-8. doi: 10.1128/JVI.00239-09. Epub 2009 Apr 8. J Virol. 2009. PMID: 19357166 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources